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Ability of Strepfomyces spp. acyl carrier proteins and 
coenzyme A analogs to serve as substrates in vitro for 
E. co/i holo-ACP synthase 
Amy M Gehringl, Ralph H Lambalotl, Kurt W Vogel*, Dale G Drueckhammer* 
and Christopher T Walsh’ 
Introduction: The polyketide natural products are assembled by a series of 
decarboxylation/condensation reactions of simple carboxylic acids catalyzed by 
polyketide synthase (PKS) complexes. The growing chain is assembled on acyl 
carrier protein (ACP), an essential component of the PKS. ACP requires 
posttranslational modification on a conserved serine residue by covalent 
attachment of a 4’-phosphopantetheine (P-pant) cofactor to yield active 
holo-ACP. When ACPs of Streptomyces type II aromatic PKS are overproduced 
in E. co/i, however, typically little or no active holo-ACP is produced, and the 
ACP remains in the inactive apo-form. 
Results: We demonstrate that E. co/i holo-ACP synthase (ACPS), a fatty acid 
biosynthesis enzyme, can catalyze P-pant transfer in vitro to the Sfreptomyces 
PKS ACPs required for the biosynthesis of the polyketide antibiotics granaticin, 
frenolicin, oxytetracycline and tetracenomycin. The catalytic efficiency of this 
P-pant transfer reaction correlates with the overall negative charge of the ACP 
substrate. Several coenzyme A analogs, modified in the P-pant portion of the 
molecule, are likewise able to serve as substrates in vitro for ACPS. 
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Conclusions: E. co/i ACPS can serve as a useful reagent for the preparation of 
holo-forms of Streptomyces ACPs as well as holo-ACPs with altered 
phosphopantetheine moieties. Such modified ACPs should prove useful for 
studying the role of particular ACPs and the phosphopantetheine cofactor in the 
subsequent reactions of polyketide and fatty acid biosynthesis. 
Introduction 
Polyketide antibiotics are synthesized either by enzymes 
of very high molecular weight with multiple catalytic 
domains in a single polypeptide chain, type I synthases 
(exemplified by 6-deoxyerythronolide B synthase), or by 
a multienzyme complex in which the required catalytic 
activities reside on discrete subunits, the type II synthases 
(exemplified in St9-eptomyces species aromatic polyketide 
biogenesis) [1,2]. In both cases, the growing carbon skele- 
ton is elongated as an acyl-S-enzyme species where the 
sulfur is part of the 4’-phosphopantetheine prosthetic 
group attached to an acyl carrier protein (ACP) module. In 
type I polyketide synthases (PKSs), the ACP module is an 
integral, constituent domain of a larger multidomain poly- 
peptide. In type II synthases, there is a separate ACP of 
B-1OkDa that associates with the other enzymatic sub- 
units of the synthase complex (Fig. 1). Thus, in Strepto- 
myces spp. producing multiple aromatic polyketides there 
will be a separate, dedicated ACP for each gene cluster 
expressed during antibiotic production [Z]. These polyke- 
tide-specific ACPs are additional to the ACP involved in 
fatty acid biosynthesis in these bacteria [3,4]. It has been 
unknown to what extent utilization of a specific ACP is 
determined by protein-protein recognition in type II PKS 
complex assembly or by selective posttranslational conver- 
sion of an inactive apo-ACP to the phosphopantetheinyl- 
containing holo-ACP, which is competent for acylation 
and chain elongation. 
There have been mixed reports on whether Streptomyces 
type II PKS apo-ACPs can be posttranslationally modified 
to produce holo-ACP during heterologous expression in 
Esdzericha coli [5,6]. If such holo-ACP formation by the 
E. COL phosphopantetheinyl transferases is of very low 
stoichiometry, it will be a limiting factor in polyketide 
biosynthesis in E. coli. We have recently reported the 
cloning, overproduction, purification and characterization 
of the E. coli enzyme holo-acyl carrier protein synthase 
(ACPS) that catalyzes apo to holo posttranslational modifi- 
cation from cosubstrate coenzyme A (CoASH), using the 
fatty acid apo-ACP as substrate (Fig. 2) [7]. E. cob ACPS 
is thus a useful reagent with which to assess the ability to 
recognize and modify Streptomyces type II PKS ACPs. 
Here, we report the ability and catalytic efficiency of 
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Schematic of the requirement of ACP 
phosphopantetheinylation for polyketide 
synthase activity. Conversion of apo-ACP 
(gray) to holo-ACP (blue) provides the 
sulfhydryl group through which the 
intermediates of polyketide biosynthesis are 
covalently attached. Yellow circles represent 
the other protein subunits of the type II 
polyketide synthase which include at least a 
f3-ketoacyl synthase (condensing enzyme) and 
a chain-length determining factor, and typically 
also include 3-ketoreductases, 
acyltransferases, dehydrases and cyclases. 
These enzymes catalyze the iterative addition 
of malonyl units followed by decarboxylation 
and condensation reactions, reductions, and 
cyclizations by which the growing polyketide 
chain is assembled and modified. 
E. coli ACPS to posttranslationally modify the purified 
apo-ACPs involved in the biogenesis of granaticin by 
S. viofaceorzlber, of frenolicin by S. roseofulvus, of oxytetracy- 
cline by S. rimosus, and of tetracenomycin by S. glaucescens 
(Fig. 3). We also observe that.CoASH analogs including 
desulfo-CoA and the dethio (carba) analog of acetyl-CoA 
can be loaded onto apo-ACP by the E. coli ACPS. 
Results 
Overproduction of apo-forms of Streptomyces spp. ACPs 
The PKS ACPs involved in the synthesis of the aromatic 
polyketide antibiotics granaticin (gra), frenolicin (fren), 
oxytetracycline (otc), and tetracenomycin (tcm; see Fig. 3) 
were overproduced in E. coli. The tcm ACP was over- 
produced with a carboxy-terminal hexahistidine (His,) 
tag; all the other ACPs were expressed in their native form. 
Overexpression of these Streptomyces ACPs in E. COL yielded 
predominantly apo-ACP that had not been modified by 
the covalent attachment of 4’-phosphopantetheine as previ- 
ously reported [5,6]. Mass spectral analysis of these ACPs 
Figure 2 
following the purification step on Q-Sepharose showed no 
significant levels of holo-protein (data not shown). The 
Streptomyces apo-ACPs were purified in several milligram 
quantities to near homogeneity in two steps using anion- 
exchange chromatography on Q-Sepharose followed by per- 
fusion chromatography on POROS ZOHQ; the His,-tagged 
tcm ACP was also further purified on a nickel-chelate resin 
(Fig. 4). Protein sequencing of the 10 amino-terminal 
residues of each ACP revealed that the amino-terminal 
methionine had been cleaved from gra, fren, and tcm ACP 
but not otc ACP. 
Streptomyces ape-ACPs are modified by E. co/i holo-ACPS 
Although it has previously been shown that the gra, fren, 
otc and tcm ACPs are not phosphopantetheinylated well 
in. &JO when overexpressed in E. co/i [5,6], the ability of E. 
coli holo-ACPS to catalyze phosphopantetheinyl transfer 
to these ACPs in vitro has not been investigated. Since 
ACP phosphopantetheinylation is required for the forma- 
tion of an active polyketide synthase, E. coli ACPS may 
&enzyme A 
3’,5’-ADP 
holo-ACP 
apo-ACP 
General reaction catalyzed by E. co/i 
holo-ACPS. ACPS catalyzes transfer of 
phosphopantetheine (blue) from CoASH to a 
conserved serine residue in the apo-ACP 
substrate to yield 3’,5’ ADP (red) and active 
holo-ACP in a magnesium-dependent 
1 reaction. 
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Figure 3 
Chemical structures of selected aromatic 
polyketide antibiotics produced by 
Streptomyces spp. Frenolicin (fren) from S. 
roseofulvus, granaticin (gra) from 
S. violaceoruber, oxytetracycline (otc) from 
S. rimosus, and tetracenomycin (tcm) from 
S. glaucescens. Apo-ACPs from each of their 
respective polyketide synthases were purified 
(Fig. 4). 
I Frenolicin Granaticin ‘6 
I Oxytetracycline Tetracenomycin 
serve as a useful reagent for the preparation of holo-PKS 
ACPs that can be used to study downstream reactions in 
polyketide biosynthesis. Mass spectral data were collected 
for each PKS ACP following incubation for several hours 
with CoASH and pure ACPS. Table 1 shows that gra, fren, 
otc, and tcmHish ACP were all modified from the apo- to 
the holo-form as indicated by an increase in mass of 
-339Da due to the addition of phosphopantetheine; mod- 
ification appeared essentially complete, as indicated by 
the absence of a mass spectral peak corresponding to the 
apo-form. It has previously been shown that apo- and 
holo-forms of E. coli ACP [8,9] and Streptomyces type II 
ACPs [6] may be separated by high performance liquid 
chromatography (HPLC). Using otc ACP as a representa- 
tive Streptomyces PKS ACP, the apo- and holo-forms were 
similarly resolved (Fig. 5); coinjection of otc apo-ACP and 
otc ACP following incubation with CoASH and ACPS 
shows two peaks at 32.6min and 33.9min, indicative 
of the transformation of otc ACP from the apo- to the 
holo-form and corroborating the mass spectral data. 
To investigate the substrate specificity of E. cob ACPS, K, 
and k,,, parameters were determined for each of the Strep- 
tomyces ACP substrates under initial velocity conditions 
(Table 2; Fig. 6). When gra ACP was the substrate, the 
reaction showed severe substrate inhibition of similar mag- 
nitude to the substrate inhibition observed with the 
cognate substrate of ACPS, the ACP of E. col’i fatty acid 
synthase (FAS) ([7]; R.S. Flugel, V.L. Healy, R.H.L. and 
C.T.W., unpublished data). The severity of the observed 
inhibition of ACPS by gra apo-ACP made an accurate 
estimation of the K, and k,,, values difficult; gra ACP, 
however, qualitatively gives the highest V,,, and as a sub- 
strate for ACPS seems to be no more than lo-fold worse 
Figure 4 
r 
Native PAGE gel (20% ) demonstrating the purity of the Streptomyces 
apo-ACPs used. Approximately 1 O-l 2 kg of each ACP was loaded. 
The upper band in the gra, otc and tcmHis, lanes most probably 
represents an apo-ACP dimer which has been previously reported [Sl, 
given that holo-ACP was not detected by mass spectrometry, that 
each of these proteins contains a single cysteine residue which is 
lacking in E. co/i and fren ACP and that the intensity of this band may 
be diminished by incubation with DTT. 
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Table 1 Figure 5 
Mass spectral data demonstrating the modification of 
Streptomyces ACPs by E. coli ACPS. I ?-- 
Substrate Molecular mass (Da) 
Before incubation After incubation 
with ACPS (apo) with ACPS (holo) 
Calculated Observed Calculated Observed 
gra ACP 8860 8863 9199 9199 
fren ACP 8664 8682 9003 9009 
otc ACP 9917 9927 10256 10260 
tcm ACP (Hiss) 10018 10020 10357 10376 
a) 
_I 
than the E. coli ACP. When fren ACP is used as the sub- 
strate, the substrate inhibition observed is considerably less 
than that for gra ACP; there is no substrate inhibition when 
tcmHis, and otc ACP are used. This attenuation of sub- 
strate inhibition is concomitant with a decrease in the cat- 
alytic efficiency of ACPS modification, with both K, and 
k,,, kinetic parameters affected. Fren ACP is an approx- 
imately four-fold poorer substrate for ACPS than gra ACP, 
while otc and tcmHis6 ACP have catalytic efficiencies 
decreased almost Z-fold when compared to gra ACP and 
about six-fold when compared to fren ACP. The poorer 
Streptomyces apo-ACP substrates are processed at a -2OO- 
fold lower catalytic efficiency than E. coli FAS apo-ACP. 
The decrease in catalytic efficiency of a Streptomyces PKS 
ACP as a substrate for E. co/i holo-ACP synthase appears to 
correlate with a decrease in the overall negative charge in 
the highly anionic ACP family (Table 2). It should be 
noted that the carboxy-terminal hexahistidine tag on the 
tcmHis6 substrate may well contribute to an increase in its 
K, value and/or a decrease in k,,, relative to the native tcm 
ACP substrate, which was not examined here. 
b) 
Processing of CoASH analogs by holo-ACP synthase 
The specificity of E. coli holo-ACPS for its coenzyme A 
substrate was also examined in endpoint assays. CoASH 
analogs with modifications in the phosphopantetheine 
portion of the molecule were tested including homo- 
cysteamine-CoA, acetonyldethio-CoA, and desulfo-CoA 
(Fig. 7). ACPS could catalyze modification of 8. co/i 
Conversion of otc ape-ACP to holo-ACP (220nm, absorbance units 
full scale (AUFS) =0.25). (a) Ott (50pM) was incubated as described 
in the Materials and methods section with CoA in the presence of 
ACPS and also in the absence of ACPS. Equal volumes (150 ~1) of the 
two assays were then mixed and 200 t.~l of this mixture was injected 
onto the HPLC Cl 8 reversed-phase column; Rt (ape-ACP) 33.9 min, 
(holo-ACP) 32.6 min. Single injections (data not shown) confirmed that 
the otc apo-ACP was quantitatively converted to the holo-form. 
(b) Sample was prepared as described above except otc ape-ACP 
was incubated with desulfo-CoA; Rt (ape-ACP) 34.2 min, (desulfo- 
holo-ACP) 33.3 min. Single injections confirmed that the otc apo-ACP 
was quantitatively converted to desulfo-holo-ACP (data not shown). 
Table 2 
Kinetic parameters for Streptomyces ACPs as substrates for 
E. coli ACPS. 
Substrate Charge (pH 7) kat k&n 
(min-l) (2, (t.~M-~rnin-l) 
E. coli ACP -14.89 80-l 00 2 (Ki= 2) 50 
gra ACP -14.09 230 25 (Ki=0.6) 6 
fren ACP -12.07 19 12 (K,=54) 1.6 
tcm ACP (His,) -11.76 5.4 22 0.25 
otc ACP -11.10 10 39 0.26 
ACP with each of these phosphopantetheine analogs as 
determined by mass spectral analysis (Table 3) and analyti- 
cal HPLC analysis (Fig. 8). Both the acetonyldethio-holo- 
ACP and the homocysteamine-holo-ACP could be well 
resolved from apo-ACP when coinjected onto the HPLC 
column (Fig. 8). The ability to use desulfo-CoA also 
extended to the modification of otc ACP as can be seen by 
its conversion to the desulfo form of the holo-protein 
(Fig. 5). The conversion of both the carba (dethia) analog of 
acetyl-CoASH and the homocysteamine form of CoASH to 
the holo-ACP form (Fig. 8) indicates that ACPS has relaxed 
specificity for the distal end of the phosphopantetheinyl 
moiety of CoASH, and suggests that it may be possible ta 
load acylpantetheines directly onto apo-ACP substrates. 
otc holo-ACP 
32.6 min 
otc apo-ACP 
33.9 min 
i 
otc desulfo-holo-ACP 
33.3 min 
\ 
otc apo-ACP 
34.2 min 
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Figure 6 Table 3 
Concentration ACP substrate (PM) 
Velocity versus substrate concentration plots for the reaction of ACPS 
with gra (black circles), fren (blue squares), otc (pink diamonds) and 
tcmHis6 (purple triangles) ape-ACP. Incubation conditions were as 
follows: gra ACP, 2 nM ACPS for 15 min; fren ACP, 18 nM ACPS for 
10 min; otc ACP, 18 nM ACPS for 15 min; tcmHiss ACP, 18 nM ACPS 
for 15 min. 
Discussion 
Study of the type II aromatic PKSs in v&o requires sufli- 
cient quantities of active holo-ACP, that has been correctly 
posttranslationally modified by the covalent attachment of 
the 4’-phosphopantetheine cofactor on which the growing 
polyketide is then assembled. Overproduction of various 
type II PKS ACPs in E. co/i, however, has yielded ACP 
exclusively or predominantly in the inactive, unmodified 
apo-form. Shen et al. [5] reported that overexpression of 
the tcm ACP in E. co/i gives no holo-ACP as detected by 
electrospray mass spectrometry, slP NMR and [3-3H] 
@-alanine labeling when cultures are induced in the expo- 
nential phase of growth; induction in the stationary phase 
of growth allows the recovery of a small percentage of tcm 
holo-ACP. Crosby et al. [6] examined the apo to holo ratio 
for gra, fren, otc and actinorhodin (act) ACP overproduced 
for 2-3 h in E. cali; about 30% and 2% of the gra and act 
ACPs respectively could be found in the holo-form, while 
Figure 7 
Mass spectral data demonstrating the modification of ACPs 
with CoA analogs catalyzed by E. co/i ACPS. 
Substrate 
E. coli ACP 
otc ACP 
CoA analog Molecular mass (Da) 
Calculated Observed 
none (apo) 8508 8513 
CoA 8847 8850 
homocysteamine-CoA 8861 8867 
acetonyldethio-CoA 8871 8906 
desulfo-CoA 8815 8828 
desulfo-CoA 10224 10236 
fren and otc ACP remained unmodified. For act ACP, 
increasing the post-induction period to 12h allowed 
SO-90% of the act ACP to be obtained in the holo-form, 
but these fermentation conditions also led to a significant 
drop in the total amount of recoverable protein [6]. Thus, 
standard overproduction approaches have not previously 
led to useful quantities of posttranslationally-modified, 
active holo-ACP species. Given the low recovery of PKS 
holo-ACPs and the implied low-level recognition of these 
substrates by E. co/i ACPS, we wished to determine if in 
vitro incubation of these PKS ACPs with pure E. co/i ACPS 
could be used for the preparation of functional PKS holo- 
ACP. Indeed, as shown by the data presented here, ACPS 
does catalyze transfer of phosphopantetheine to gra, fren, 
otc and tcm ACP to give near quantitative conversion of 
these proteins from their apo- to holo-forms. 
The PKS ACPs examined here are also of interest 
for delineation of the substrate specificity of the 
E. co/i holo-ACP synthase. ACPS will catalyze in vitro 
phosphopantetheinyl transfer to D-alanyl carrier protein 
(9kDa) from Lactobacdhs casei involved in the D-alanyla- 
tion of lipoteichoic acid [lo] and also to NodF from 
Rhizobium leguminosancm (9.9kDa) involved in the 
biosynthesis of a lipo-chitin oligosaccharide molecule 
(R.H.L., A.M.G., C.J.W., T. Ritsema and H.P. Spaink, 
unpublished observations). But, ACPS will not transfer 
phosphopantetheine to PCP (13 kDa), a peptidyl carrier 
protein domain derived from the type I non-ribosomal 
Chemical structures of the coenzyme A 
analogs used in this study. X=CH,SH 
X=CH,CH,SH 
Coenzyme A 
Homocysteamine-CoA 
HO 9 
o=fl-o- 
0- 
X=CH, Desulfo-CoA 
X=CH,CH,COCHs Acetonyldethio-CoA 
L I 
22 Chemistry & Biology 1997, Vol 4 No 1 
Figure 8 
a) 
acetonyldethio-holo-ACP 
30.1 min 
apo-ACP 
33.6 min 
( W 
homocysteamine-holo-ACP 
32.3 min 
apo-ACP 
34.6 min 
d 
Modification of f. co/i ACP with CoA analogs catalyzed by ACPS 
(220 nm, AUFS= 1 .O). (a) Apo-ACP (500 FM) was incubated with 
125 uM acetonyldethio-CoA in the presence and absence of 1.5 ~.LM 
ACPS. Equal volumes (150 $) of the two assays were then mixed and 
200 ~1 of this mixture was injected onto the HPLC Cl 8 reversed-phase 
column; R, (ape-ACP) 33.6 min, (acetonyldethio-holo-ACP) 30.1 min. 
Single injections (data not shown) confirmed that the ape-ACP was 
quantitatively converted to the modified holo-form. (b) Sample was 
prepared as described above except apo-ACP was incubated with 
homocysteamine-CoA; R, (ape-ACP) 34.6 min, (homocysteamine-ACP) 
32.3min. Single injections confirmed that the apo-ACP was quanti- 
tatively converted to homocysteamine-holo-ACP (data not shown). 
peptide tyrocidine A synthetase responsible for tyrocidine 
production in Bacillzls brevis. This dichotomy has led to 
our detection of a second class of phosphopantetheinyl 
transferases that recognize the apo-ACP domains in the 
multidomain peptide synthetases [ll]. 
It is, therefore, of considerable interest to determine the 
effectiveness of ACPS as a phosphopantetheinylating 
agent for the ACPs involved in polyketide biosynthesis. 
The gra, fren, otc, and tcm ACPs have 19523.4% 
similarity to the E. coli FAS ACP. The kinetic studies pre- 
sented here indicate that, despite the fact that they all 
have approximately the same degree of similarity to E. co/i 
ACP, there is a 25fold range in the catalytic efficiencies of 
these PKS ACPs as substrates for ACPS, in the order 
E. coL ACP>gra ACP>fren ACP>tcmHis6, otc ACP, that 
correlates with the degree of overall negative charge of 
these proteins (Table 2). The more negatively-charged an 
ACP substrate is, the more efficient a substrate this 
protein appears to be for ACPS. This hypothesis is sup- 
ported by kinetic data determined for the reaction of 
ACPS with NodF; with an overall charge at pH7 of 
-10.07, NodF gives a k,dK, value of 0.05l.~M-~ min-’ 
(A.M.G., C.T.W., T. Ritsema and H.P. Spaink, unpub- 
lished observations). The tyrocidine PCP substrate, with 
its essentially neutral charge, is not a substrate for ACPS 
[ 11,121, but as it is a 115 amino acid (aa) domain dissected 
from a 1087 aa type I nonribosomal peptide synthetase, 
structural factors may contribute to its inability to serve as 
a substrate. An increase in negative charge also correlates 
with an increased ability of an apo-ACP substrate to 
inhibit ACPS; both E. COL apo-ACP and gra apo-ACP are 
severe substrate inhibitors of ACPS, while fren apo-ACP 
is a weaker inhibitor and tcmHis6 and otc apo-ACP do not 
inhibit ACPS. Given the complications of kinetic analysis 
when substrate inhibition is a factor, tcmHis, and otc 
ACP may prove more tractable substrates for further 
examination of the mechanism of holo-ACP synthase. 
Genes encoding phosphopantetheinyl transferase(s) in 
Streptomyces spp. have not yet been identified. A crude 
extract from S. coeLico/oor can catalyze incorporation of phos- 
phopantetheine into the E. coli ACP, but the protein(s) 
responsible have not been purified (A.M.G., Carreras, C., 
Khosla, C. and C.T.W., unpublished observations). It is 
not yet clear whether Streptomyces spp. will possess a uni- 
versal phosphopantetheinyl transferase or multiple phos- 
phopantetheinyl transferases. Multiple ACPs have been 
identified in S. coehcolor and S. glaucescens. In S. glaucescens, 
a constitutive ACP presumably involved in fatty acid 
biosynthesis is encoded by the fabC gene while the tcmM 
gene encodes the tetracenomycin biosynthesis ACP [3]. In 
S. coe/ico/orA3(‘2), a constitutive fatty acid ACP encoded by 
the acpP gene has also been identified which, with the 
ACP genes found in the act (actinorhodin biosynthesis) 
and whiE (spore pigment biosynthesis) PKS gene clusters, 
brings the number of different ACPs in this organism to 
three [4]. The S. coe&oLoor FAS ACP gene was unable to 
replace the act ACP gene for the production of acti- 
norhodin in viva [4], indicating the functional separation of 
the FAS and PKS pathways. The malonyl-coenzyme 
A:ACP acyltransferase in S. g/aucescens [3] and S. coeLco/oor 
A3(2) [13], however, appears to function in both fatty acid 
and polyketide biosynthesis. It will be interesting to deter- 
mine if activation of ACPs by phosphopantetheinylation 
represents another point of divergence and/or specificity 
between the FAS and PKS pathways. In E. co& two and 
possibly three phosphopantetheinyl transferases have 
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been identified (ACPS, EntD, 0195) each with clear 
specificity for their cognate substrates [ll]. 
Significance 
The feasibility of generating holo-ACPs with altered 
phosphopantetheine moieties has been demonstrated in 
this study by testing several coenzyme A analogs as sub- 
strates for ACPS. Since CoA analogs modified in the 
pantetheine arm are readily available, it should now be 
possible to routinely generate preparative quantities of 
holo-ACPs with phosphopantetheine groups of altered 
composition, length and reactivity. This opens the door 
to studies of the role of phosphopantetheine in the subse- 
quent reactions of acyltransfer, condensation, reduction, 
dehydration and cyclization in fatty acid and polyketide 
biosynthesis. For example, the desulfopantetheinyl and 
the acetonyldethiopantetheinyl holo-ACP forms may 
be selective inhibitors of particular steps in polyketide 
elongation. Similarly, in lieu of an as yet uncharacter- 
ized Streptomyces phosphopantetheinyl transferase, the 
ability of ACPS to modify the PKS ACPs studied here 
makes it a valuable reagent for the large-scale prepara- 
tion of active PKS holo-ACP for further enzymatic 
studies. Also, coexpression of streptomycete apo-ACP 
molecules in an E. coli strain overproducing the E. coli 
holo-ACP synthase should yield functional holo-ACP 
and species competent for aromatic polyketide assembly. 
Materials and methods 
Overproduction and purification of Streptomyces apo-ACPs 
Plasmids containing genes for the following Strepfomyces PKS acyl 
carrier proteins were kindly provided by Chaitan Khosla, Stanford. 
University: granaticin ACP (S. v;olaceoruuber), frenolicin ACP (S. roseo- 
fulvus), oxytetracycline ACP (S. rimosus) and tetracenomycin ACP 
(S. glaucescens). These plasmids were used as the templates for PCR 
amplification of these genes using the following primers: gra ACP 
forward primer: 5’-TXCAGCTAGGATCATATGGCTCGTCTGACC- 
CTGGACGGTCTGCG-3’, gra ACP reverse primer: 5’-GAlTAGTCA- 
CAAGCmCAGGCCGCCTCGGCCTGGGC-3’; fren ACP forward 
primer: 5’-ACATTCAGGATACCATATGAGCGCACTGACCGTTGA- 
CGAC-3’, fren ACP reverse primer: 5’-AATGGCGAATAAGCTTTC- 
AGGCGGTGGCCGGGGTGGTGTT-3’; otc ACP forward primer 
5’-GATCTCATGCACACATATGACCCTGCTGACCCTGTCCGA-3’, 
otc ACP reverse primer 5’-AACTCGATGCAAGC777CAClTGTCC- 
CGCGCGGCGCCA-3’; tcm ACP forward primer 5’sAAGTGCGAT- 
GCGACATATGCCGCAGATCGGCCTGCCGCGTCTCGTC-3’, tcm 
ACP reverse primer: 5’-GTAGCTTAGCAAGCmCAGGCGACCTC- 
CCCGGCCGTCTC-3’ (all primers from Integrated DNA Technolo- 
gies). The forward primers introduce an Ndel restriction site (italic) 
while the reverse primers introduce a HindIll restriction site (italic). 
In addition, the forward primers optimized the codon usage for the first 
eight codons of the ACP genes to facilitate expression in E. co/i. The 
NdellHindlll-digested PCR product was cloned into pET22b 
(Novagen) and transformed into competent DH5a and BL21 (DE3) f. 
co/i cells. The identity of the recombinant ACP genes was confirmed 
by DNA sequencing (Biopolymer Laboratory, Department of Biological 
Chemistry and Molecular Pharmacology, Harvard Medical School). 
Surprisingly, DNA sequencing revealed that the tcm ACP gene had 
inadvertently been obtained with a carboxy-terminal His, tag supplied 
by the pET22b vector and appending the amino acid sequence 
LEHHHHHH to the overexpressed tcm ACP. 
Cultures of BL21 (DE3)pET22b-gra, BL21 (DE3)pET22b-fren, BL21 
(DE3)pET22b-otc, and BL21 (DE3)pET22b-tcmhis, (2x 1 I, 2xYT 
media) were each grown at 37’C to an optical density (O.D.) of 
0.5-0.8 and then induced with 1 mM isopropyl-/3-o-thiogalactopyra- 
noside (IPTG). Growth continued for 3-4 h and cells were harvested 
by centrifugation. The overproduced ACPs were released and purified 
by a variation of the freeze/thaw method of Morris et al. [14]. The 
harvested cells were frozen as a cell pellet at -80°C for 24 h and then 
thawed in buffer A (50 mM Tris.HCI, 2 mM dithiothreitol (DTT), 2 mM 
EDTA, pH 7.5) to release the overexpressed ACPs without lysing 
the cells. This freeze/thaw supernatant was then loaded onto a 
Q-Sepharose column (2.5x 10 cm) which had previously been equili- 
brated with buffer A. For purification of gra ACP, a 200 ml gradient of 
O-0.4M KCI (in buffer A) followed by 400ml of a gradient from 
0.4-0.8 M  KCI was then applied at a flow rate of 2 ml min-l with ACP 
eluting at -0.4M salt as indicated by 20% native PAGE of the column 
fractions. For purification of fren ACP, 150 ml of a O-O.3 M  KCI gradi- 
ent (in buffer A) was followed by a 300 ml 0.3-0.6 M  KCI gradient and 
a 150 ml 0.6-0.8 M  KCI gradient with ACP again eluting at -0.4 M  
salt. For otc ACP purification, the column was washed with buffer A 
(lOOmI) and gradients of O-0.2M KCI (150ml), 0.2-0.5M KCI 
(300ml) and 0.5-0.8 M  KCI (50ml) were applied (ACP elutes at 
-0.28M KCI). Finally, for tcmHis, ACP purification, the column was 
washed with 50 ml buffer A and gradients of O-O.25 M KCI (150 ml), 
0.25-0.55M KCI (300ml) and 0.55-0.8 M  KCI (100 ml) applied 
(ACP elutes at -0.35 M KCI). Fractions containing each ACP as 
judged by 20% native PAGE were pooled and dialyzed against 2 I 
buffer A. At this stage in the purification, a sample of each ACP was 
submitted for amino-terminal protein sequencing (1 Ocycles) and 
MALDI-TOF mass spectral analysis (Howard Hughes Medical Institute 
Biopolymer Facility, Harvard Medical School). 
To obtain samples of each ACP purified to near homogeneity, the 
BioCAD” SPRINT perfusion chromatography system (PerSeptive 
Biosystems, Inc.) was used. A portion of the dialyzed ACP samples 
following Q-sepharose chromatography was applied to a POROS 
20HQ anion-exchange column at a flow rate of lOmlmin-‘. The 
optimum pH for separating the ACPs from the remaining contaminants 
was determined to be gra ACP, pH 9.0; fren ACP, pH 6.0; otc ACP, pH 
9.0; and tcmHis, ACP, pH 9.0. Proteins were eluted with a gradient of 
O-0.5M NaCl in 1OmM Tris, 1OmM Bis-tris propane of the indicated 
pH. The tcmHiss ACP sample was additionally purified by nickel chelate 
chromatography according to the manufacturer’s instructions (Novagen). 
The buffer was exchanged for 50mM Tris.HCI, pH 8.0 and the protein 
samples concentrated using Centriprep 3 (Amicon). Protein concentra- 
tion was determined by measuring the absorbance at 280 nm using the 
following calculated extinction coefficients [15]: gra ACP 1400 M-’ cm-‘, 
fren ACP 2560 M-j cm-‘, otc ACP 2680 M-l cm-l, and tcmHis, ACP 
2680 M-l cm-‘. 
Preparation of the CoASH analogs 
Desulfocoenzyme A was purchased from Sigma Chemical Company. 
Acetonyldethio-coenzyme A was prepared as described previously 
[16]. Homocysteamine-coenzyme A was prepared as follows. A 
suspension of 0.88 g homocysteamine hydrochloride [17,181 in 1 ml 
H,O was added to 1 Omg adenosine 5’s(trihydrogen diphosphate) 
3’-(dihydrogen phosphate) 5’-[(R)-3-hydroxy-4-[[3-[propylthiol-3-oxo- 
propyllaminol-2,2-dimethyl-4-oxobutyl] ester [19] in 1 ml H,O and the 
pH adjusted to 10 with 6 M  NaOH. The reaction was stirred at room 
temperature while nitrogen was gently bubbled through the solution. 
The reaction was monitored by analytical HPLC and complete disap- 
pearance of the starting CoA synthon (R, = 17.3 min) and appearance 
of product (R,=l3,7min) was observed in 4 h. The reaction was fil- 
tered, the pH was adjusted to 4.5, and the product partially purified by 
preparative HPLC (5 min 50/o methanol (solvent B) followed by a linear 
gradient to 45% B over 40min, product eluted at 25-32 min). The 
product was further purified on a DEAE-Sepharose column (20x2.5 
cm, O-0.2M NaCl pH 2.8, product eluted at 0.13M NaCI) to yield 
4.5 mg homocysteamine-CoA. A,,,,,= 260 nm. ‘H NMR (as potassium 
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salt, 400mHz, D,O): 6 0.724 (s, 3H), 0.852 (s, 3H), 1.65-1.72 (n-i, 
2H), 2.392 (t, 2H, J=6.4 Hz), 2.447 (t, 2H, J=7.0 Hz), 3.174 (t, 2H, 
J=6.8 Hz), 3.409 (t, 2H, J=6.2 Hz), 3.516 (dd, lH, J=4.8, lO.OHz), 
3.785 (dd, 1 H, J=4.8, 10.0 Hz), 3.962 (s, 1 H), 4.195 (br s, 2H), 
4.551 (br s, lH), 6.160 (d, lH, J=6.0 Hz), 8.306 (s, 1 H), 8.561 (s, 
1 H). Mass Spec HRMS (FAB): (M-H+)- calc’d for C,,H,,N,O,,P,S 
m/z 780.191, found 780.126. 
Analytical and preparative-scale HPLC experiments were performed 
using a Perkin-Elmer 250 HPLC with a PE LC-235 diode array detec- 
tor and a gradient of methanol (solvent B) in aqueous potassium 
phosphate (solvent A, 50mM KHzPO, for analytical runs, 1 OmM 
KH,PO, for preparative runs). Analytical HPLC was done on a Rainin 
Microsorb Cl8 column (4.6 mmx25cm) with monitoring at 215 and 
260nm. Compounds were eluted with a flow rate of 1 mlmin-’ 
with 5% solvent B for 2min, followed by a linear gradient to 60% 
solvent B over 12 min, and then maintained at 60% solvent B. Prepar- 
ative scale HPLC was done on a Rainin Microsorb Cl8 column 
(21.4 cm x 25 cm) with monitoring at 215 and 280 nm and a flow rate 
of 10 ml min-I. Mass spectral analysis was performed at the University 
of California at Riverside Mass Spectrometry Facility, Riverside, CA. 
The concentrations of CoA analog solutions were determined using 
& 260=1 5400 M-‘cm-l. 
Assay for apo-ACP to holo-ACP conversion by transfer of 
3H-phosphopantetheine from 3H-coenzyme A 
The radioassay for determination of phosphopantetheinyl transferase 
activity has been previously described [7,9,111. Briefly, in a final 
volume of 100 f.d, substrate (ape-gra, fren , otc or tcmHis, ACP) was 
incubated with 75mM TrisHCI, pH 8.8, 1 OmM MgCI,, 25mM DTT, 
220 J.LM [3HI-(pantetheinyl)-CoASH (specific activity 105 J.&i bmol-1, 
700/o label in phosphopantetheine portion of the molecule) and E. co/i 
holo-ACP synthase (prepared as described in [71) at an appropriate 
concentration at 37°C for a specified time. Reactions were quenched 
with 800 p,l 10% trichloroacetic acid (TCA), bovine serum albumin 
(375kg) was added as a carrier, and protein precipitate pelleted by 
centrifugation. This pellet was washed 3x with 10% TCA and the 
pellet was dissolved in 1 M Tris base. The amount of radiolabel incor- 
porated into the solubilized protein pellet was then determined by 
liquid scintillation counting. For the K,,, measurements of the Strepto- 
myces ACPs as substrates for holo-ACP synthase, the following condi- 
tions were used: gra ACP was incubated at varying concentrations 
over the range 5-60 p,M with 2 nM ACPS for 15 min; fren ACP (range 
5-80pM) was incubated with 18nM ACPS for 1Omin; otc ACP 
(range 5-180 ~.LM) was incubated with 18 nM ACPS for 15 min; 
tcmHis, ACP (5-100 JLM) was incubated with 18nM ACPS for 
15 min. The amount of tritium incorporation at each ACP concentration 
was determined in triplicate. Samples of each Streptomyces ACP were 
submitted for MALDI-TOF mass spectral analysis following incubation 
for several hours with 1.8 p,M ACPS using the same conditions 
described for the radioassay except that 2mM CoASH or 200 FM 
desulfoCoA was used as indicated. 
HPLC and mass spectrometry assay for modification of ACPs 
In a 1.5-ml microcentrifuge tube, 1 mM CoA (or 125 PM CoA analog), 
500pM apo-ACP (or ~OJ.LM otc apo-ACP), 20 mM MgCI,, 10 mM 
DTT, 150 mM TrisHCI, pH 8.8, and 1.5 p,M ACPS (100 )LI final volume) 
were incubated at 37’C for 30 min. Reactions for HPLC analysis were 
quenched with 9OOpI 0.1% trifluoroacetic acid (TFA). A sample 
(200 )LI) of this solution was injected onto a Cl 8 reversed phase analy- 
tical column (Vydac) which had been equilibrated with 15% iso- 
propanol in 0.1% TFA (eluant A) at 0.5 ml mini. Absorbance at 220 
nm was monitored. The sample was eluted from the column with 2.5 ml 
lOOo/, A, a 1 Oml linear gradient to 40% B (75% isopropanol in 0.1% 
TFA), followed by a 7.5ml linear gradient to 100% B at a constant 
flow rate of 0.5ml min-l. Under these conditions holo-ACP elutes 
before apo-ACP. Samples for MALDI-TOF mass spectrometry analysis 
were submitted as the crude incubation mixtures (Biopolymers Facility, 
Howard Hughes Medical Institute, Harvard Medical School). 
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